Drug Shortage Report for PRALUENT

Last updated on 2019-02-27 History
Report ID 73630
Drug Identification Number 02453835
Brand name PRALUENT
Common or Proper name Praluent
Company Name SANOFI-AVENTIS CANADA INC
Active Ingredient(s) ALIROCUMAB
Strength(s) 150MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2
ATC code C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-02-18
Actual start date
Estimated end date 2019-02-28
Actual end date 2019-02-26
Shortage status Resolved
Updated date 2019-02-27
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-02-27 English Compare
v7 2019-02-26 French Compare
v6 2019-02-26 English Compare
v5 2019-02-26 French Compare
v4 2019-02-26 English Compare
v3 2019-02-19 English Compare
v2 2019-01-25 French Compare
v1 2019-01-25 English Compare